NCT04663997: 177 LuPSMA-617 vs Docetaxel in Metastatic Castration Resistant and PSMA-Positive Prostate Cancer
- State
- Under way
- Phase
- Phase 2
- People
- 200 taking part
- Started
- 11 Aug 2021
- Primary completion
- 25 Aug 2025
- Arms
- 177 Lu-PSMA-617
- Results
- None posted
- 11 Dec 2020: Trial registered
- 11 Aug 2021: Trial started